VIRTUAL EVENT
The 4th Annual Gene Therapy for Rare Disorders will focus exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market.
SCB will be speaking at this event.
The 4th Annual Gene Therapy for Rare Disorders will focus exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market.
SCB will be speaking at this event.
By signing up, you’re agreeing to receive email from SCB. But rest assured: we respect your privacy.